- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT07857811
Evaluation of Aortic-Radial Blood Pressure Gradient in Pediatric Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass (GARP)
Invasive blood pressure monitoring is essential during heart surgery. Usually, doctors measure blood pressure using a small tube (a catheter) placed in an artery, typically in the wrist or arm. During surgeries that require a heart-lung machine (cardiopulmonary bypass), doctors can also measure blood pressure directly near the heart in the main artery (the aorta). This is done using a tube already in place for the machine, so no extra procedure is needed.
In adult patients, doctors have noticed that blood pressure readings taken at the arm can sometimes be significantly different from readings taken near the heart right after coming off the heart-lung machine. This difference could lead to unnecessary or incorrect treatments if medical teams rely only on arm readings. However, it is still unknown whether this same difference occurs in children.
The goal of this study is to measure and compare blood pressure from both the arm and near the heart in children aged 3 years and younger as they come off the heart-lung machine during heart surgery. This research will help medical teams make safer, more accurate treatment decisions for children undergoing heart surgery.
Přehled studie
Postavení
Detailní popis
Accurate arterial blood pressure monitoring is essential during and after cardiopulmonary bypass (CPB) in pediatric cardiac surgery. However, a significant gradient between radial and central aortic pressure has been reported, which could lead to erroneous clinical decisions if radial pressure is overestimated. Although this phenomenon has been studied in adults, its incidence, associated factors, and clinical implications in pediatric patients under 3 years of age remain to be clearly established.
This study proposes a prospective observational cohort design including 100 patients under 3 years of age undergoing cardiac surgery with CPB and invasive radial arterial monitoring. The study will evaluate the incidence of a significant radial-to-aortic gradient (defined as a >20% difference in SBP or >10% in MAP sustained for more than 5 minutes), alongside biometric and surgical risk factors, and its relationship with clinical outcomes such as vasoactive drug requirements, blood transfusions, and duration of mechanical ventilation.
Statistical analysis will be performed using descriptive statistics, bivariate testing, and multivariate LASSO logistic regression. This study is expected to identify a pediatric risk profile for developing a significant pressure gradient, thereby optimizing decision-making regarding arterial monitoring sites and post-CPB hemodynamic management. Ultimately, this research aims to address a clinically relevant knowledge gap and enhance perioperative safety in this highly vulnerable population.
Typ studie
Zápis (Odhadovaný)
Kontakty a umístění
Studijní kontakt
- Jméno: Santiago Arze, MD
- Telefonní číslo: +56955049217
- E-mail: sarze@uc.cl
Studijní záloha kontaktů
- Jméno: Valeria Pizarro, MD
- Telefonní číslo: +56962283715
- E-mail: vale.pizarro@uc.cl
Studijní místa
-
-
Santiago Metropolitan
-
Santiago, Santiago Metropolitan, Chile, 8320000
- Nábor
- Pontificia Universidad Católica de Chile
-
Santiago, Santiago Metropolitan, Chile, 8320000
- Nábor
- Red de Salud UC Christus
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Metoda odběru vzorků
Studijní populace
Pediatric patients from 0-3 years of age
Popis
Inclusion Criteria:
- Patients from 0 to 3 years old
- Cardiac surgery with cardiopulmonary bypass (CPB)
- Invasive blood pressure monitoring via radial artery
Exclusion Criteria:
- Patients in whom radial cannulation is not achieved
- Significant vascular malformations that may interfere with or contraindicate invasive radial blood pressure measurement
- Emergency surgeries
- Reinterventions during the same hospital stay
- Technical complications preventing reliable direct aortic pressure measurement
Studijní plán
Jak je studie koncipována?
Detaily designu
- Observační modely: COHORT
- Časové perspektivy: PROSPECTIVE
Kohorty a intervence
Skupina / kohorta |
Intervence / Léčba |
|---|---|
|
Study group
Patients under 3 years of age undergoing cardiac surgery with cardiopulmonary bypass (CPB) at the UC-Christus Clinical Hospital. |
Placement of a pressure transducer at the accessory port of the cardiopulmonary bypass (CPB) arterial cannula during the final phase of CPB and the immediate post-CPB period. |
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
To evaluate the occurrence of a significant radial-to-aortic (R-Ao) pressure gradient during the immediate post-cardiopulmonary bypass (CPB) period
Časové okno: within 15 minutes from the weaning of the CBP
|
A significant radial-to-aortic (R-Ao) pressure gradient is defined as a >20% difference in SBP or >10% difference in MAP sustained for >5 minutes) during the immediate post-cardiopulmonary bypass (CPB) period |
within 15 minutes from the weaning of the CBP
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
To determine the incidence of the R-Ao gradient in pediatric patients undergoing cardiac surgery with CPB and compare it with reported rates in the adult literature.
Časové okno: Within the first 15 minutes after CPB weaning.
|
R-Ao Gradient Incidence: percentage of positive finding to the total of recruited patients in the study. Reported Rates in adult population: As per an exhaustive review of previous literature. |
Within the first 15 minutes after CPB weaning.
|
|
To identify risk factors associated with a higher R-Ao gradient, based on patient biometric parameters and surgical variables
Časové okno: From enrollment to 48 hours after surgery
|
Patient variables: age, body surface area [BSA], radial artery diameter Surgery variables: CPB duration and use of hypothermia Outcome Measure: Odds Ratio |
From enrollment to 48 hours after surgery
|
|
To compare vasoactive drug requirements/dosages between patients with and without a significant arterial gradient
Časové okno: within 30 minutes from the weaning of the CBP, up to 48 hours after surgery.
|
The comparison will be made using VIS score, as: VIS = dopamine + dobutamine + (100 × epinephrine) + (100 × norepinephrine) + (10 × milrinone) + (10,000 × vasopressin) It will be measured at three time periods: 30 mins post CPB, Postoperative Day 1 and Postoperative Day 2 |
within 30 minutes from the weaning of the CBP, up to 48 hours after surgery.
|
|
To compare the duration of invasive mechanical ventilation between patients with and without a significant arterial gradient.
Časové okno: within the first 48 hours following weaning of the CBP
|
within the first 48 hours following weaning of the CBP
|
|
|
To compare the incidence of post-CPB blood transfusion between patients with and without a significant arterial gradient.
Časové okno: within the first 48 hours following weaning of the CBP
|
within the first 48 hours following weaning of the CBP
|
|
|
To compare the incidence of renal dysfunction between patients with and without a significant arterial gradient.
Časové okno: within 48 hours following weaning of the CBP
|
within 48 hours following weaning of the CBP
|
Spolupracovníci a vyšetřovatelé
Vyšetřovatelé
- Vrchní vyšetřovatel: Santiago Arze, MD, División de Anestesiología, Pontificia Universidad Católica de Chile
Publikace a užitečné odkazy
Obecné publikace
- Stern DH, Gerson JI, Allen FB, Parker FB. Can we trust the direct radial artery pressure immediately following cardiopulmonary bypass? Anesthesiology. 1985 May;62(5):557-61. doi: 10.1097/00000542-198505000-00002.
- Jacquet-Lagreze M, Costescu A, Denault A. Can we trust radial artery pressure monitoring for cardiac surgery? Can J Anaesth. 2022 Nov;69(11):1319-1326. doi: 10.1007/s12630-022-02321-1. Epub 2022 Oct 5. No abstract available.
- Bouchard-Dechene V, Kontar L, Couture P, Perusse P, Levesque S, Lamarche Y, Denault AY; Montreal Heart Institute Research Team. Radial-to-femoral pressure gradient quantification in cardiac surgery. JTCVS Open. 2021 Aug 5;8:446-460. doi: 10.1016/j.xjon.2021.07.031. eCollection 2021 Dec.
- Dhanyee AS, Parida S, Thangaswamy CR, Jha AK, Rajappa M, Munuswamy H, Mishra SK. Relationship between difference of preoperative and cardiopulmonary bypass mean arterial pressure, and acute kidney injury in cardiac surgical patients undergoing valve surgery. Perfusion. 2025 Jan;40(1):164-173. doi: 10.1177/02676591231226161. Epub 2024 Jan 5.
- Oh AR, Hong KY, Park J, Her S, Lee JH. Risk factors for femoral-to-radial artery pressure gradient after weaning from cardiopulmonary bypass: a historical cohort study. Can J Anaesth. 2022 Nov;69(11):1330-1339. doi: 10.1007/s12630-022-02320-2. Epub 2022 Oct 6.
- Pauca AL, Hudspeth AS, Wallenhaupt SL, Tucker WY, Kon ND, Mills SA, Cordell AR. Radial artery-to-aorta pressure difference after discontinuation of cardiopulmonary bypass. Anesthesiology. 1989 Jun;70(6):935-41. doi: 10.1097/00000542-198906000-00009.
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Aktuální)
Dokončení studie (Odhadovaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další identifikační čísla studie
- 250425011
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .